Addressing public health challenges through behavioral interventions

Manufacturing capacity, safety and increasing costs are among the main concerns for drug manufacturers and CMOs. These crucial elements are also driving development within the

Chro­ma Med­i­cine laid off an undis­closed num­ber of em­ploy­ees ear­li­er this week, as the pri­vate­ly held start­up fo­cus­es its re­sources on mov­ing its first epi­ge­net­ic